These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29033567)

  • 41. Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis.
    Li Y; Zhang T; Zhang J; Liu Q; Jia Q; Chen W; Tang Q; Xiong Y; Xia Y; Xu Y; Mo L; Huang Y; He J
    Biomaterials; 2023 Oct; 301():122232. PubMed ID: 37418856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis.
    Hu M; Wang Y; Liu Z; Yu Z; Guan K; Liu M; Wang M; Tan J; Huang L
    Nat Nanotechnol; 2021 Apr; 16(4):466-477. PubMed ID: 33495618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl
    Chang CC; Yang Y; Gao DY; Cheng HT; Hoang B; Chao PH; Chen LH; Bteich J; Chiang T; Liu JY; Li SD; Chen Y
    J Drug Target; 2018; 26(5-6):516-524. PubMed ID: 29251522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells.
    Martí-Rodrigo A; Alegre F; Moragrega ÁB; García-García F; Martí-Rodrigo P; Fernández-Iglesias A; Gracia-Sancho J; Apostolova N; Esplugues JV; Blas-García A
    Gut; 2020 May; 69(5):920-932. PubMed ID: 31530714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addressing liver fibrosis with liposomes targeted to hepatic stellate cells.
    Adrian JE; Poelstra K; Kamps JA
    J Liposome Res; 2007; 17(3-4):205-18. PubMed ID: 18027241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
    Zhang CY; Yuan WG; He P; Lei JH; Wang CX
    World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation.
    Ullah A; Wang K; Wu P; Oupicky D; Sun M
    Int J Nanomedicine; 2019; 14():2927-2944. PubMed ID: 31118614
    [No Abstract]   [Full Text] [Related]  

  • 48. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.
    Elsharkawy AM; Oakley F; Mann DA
    Apoptosis; 2005 Oct; 10(5):927-39. PubMed ID: 16151628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK; Yim HJ
    Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles.
    Xiang L; Wang X; Jiao Q; Shao Y; Luo R; Zhang J; Zheng X; Zhou S; Chen Y
    Acta Biomater; 2023 Sep; 168():497-514. PubMed ID: 37507035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia.
    Ribera J; Vilches C; Sanz V; de Miguel I; Portolés I; Córdoba-Jover B; Prat E; Nunes V; Jiménez W; Quidant R; Morales-Ruiz M
    ACS Nano; 2021 Apr; 15(4):7547-7562. PubMed ID: 33720693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.
    Narmada BC; Kang Y; Venkatraman L; Peng Q; Sakban RB; Nugraha B; Jiang X; Bunte RM; So PT; Tucker-Kellogg L; Mao HQ; Yu H
    Hum Gene Ther; 2013 May; 24(5):508-19. PubMed ID: 23527815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies.
    Iredale JP; Pellicoro A; Fallowfield JA
    Dig Dis; 2017; 35(4):310-313. PubMed ID: 28467988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis.
    Qiao JB; Fan QQ; Zhang CL; Lee J; Byun J; Xing L; Gao XD; Oh YK; Jiang HL
    J Control Release; 2020 May; 321():629-640. PubMed ID: 32135224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sorafenib-loaded silica-containing redox nanoparticles for oral anti-liver fibrosis therapy.
    Tran HT; Vong LB; Nishikawa Y; Nagasaki Y
    J Control Release; 2022 May; 345():880-891. PubMed ID: 35395328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging.
    Mulder WJ; Strijkers GJ; van Tilborg GA; Cormode DP; Fayad ZA; Nicolay K
    Acc Chem Res; 2009 Jul; 42(7):904-14. PubMed ID: 19435319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis.
    Wang JN; Li L; Li LY; Yan Q; Li J; Xu T
    Gene; 2018 Oct; 674():57-69. PubMed ID: 29944952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis.
    Tao L; Wu L; Zhang W; Ma WT; Yang GY; Zhang J; Xue DY; Chen B; Liu C
    Life Sci; 2020 Jul; 253():117572. PubMed ID: 32201276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hepatic fibrosis: almost there.
    Albanis E; Safadi R; Friedman SL
    Curr Gastroenterol Rep; 2003 Feb; 5(1):48-56. PubMed ID: 12530948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.